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DOI: 10.1039/b915159cA photoluminescent II–VI group semiconductor nanocrystal (NC)-based signaling platform composed
of thioglycolic acid capped CdS NCs and acetylcholinesterase-acetylthiocholine enzyme catalytic
reaction system was developed that was shown to be highly sensitive to nerve agents and toxic
organophosphate pesticides with detection limits down to sub-nM levels. This new sensing protocol
does not require troublesome conjugation of biomacromolecules onto the surface of NCs.Introduction
II–VI group semiconductor nanocrystals (NCs) have attracted
tremendous interest in sensing and imagining due to their unique
photophysical properties.1 A variety of biosensing strategies have
been developed by using photoluminescent II–VI group semi-
conductor NCs.2 Most of them rely on directly conjugating
biomacromolecules onto the surface of NCs, monitoring enzyme
activity and/or analyte concentration. The size of NCs at the
nanometer scale is close to that of many biomacromolecules,
which limits the number of biomacromolecules that can tether
onto the surface of NCs. Also, bioconjugation processes, that
often involve covalent and electrostatic interactions, may affect
biological functions and labeling stability of the biomolecules
and the photophysical properties of NCs.3 Therefore, simple and
feasible strategies for constructing biosensing systems based on
photoluminescent II–VI group semiconductor NCs remains
a challenging subject. Herein we report a facile signaling strategy
highly sensitive for nerve agents and highly toxic organophos-
phate pesticides (OPs), that uses thioglycolic acid (HSCH2CO2H,
TGA) capped CdS NCs (Scheme 1). In this protocol, no bio-
conjugation of biomacromolecules on the surface of NCs is
needed.
It is known that OPs, by inhibiting the activity of acetylcho-
linesterase (AChE), lead to in vivo accumulation of acetylcholine,
thereby resulting in serious impairment on nerve functions and
even death.4 Highly toxic OPs such as nerve agents and organ-
ophosphate pesticides therefore severely threaten public safety.
Efficient and rapid detection of OPs has thus become very
important and related research is active.5 II–VI group semi-
conductor NC-based assay and detection of OPs have been
documented in the literature.6–8 For example, Willner et al.6aDepartment of Chemistry and The MOE Key Laboratory of Analytical
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This journal is ª The Royal Society of Chemistry 2009reported several II–VI group semiconductor NC-based sensing
systems for AChE inhibitors, under the mechanisms of photonic
sensing, surface plasmon resonance, and biocatalytic cascade
reactions. Leblanc et al.7 developed two sensing systems for
paraoxon by incorporating CdSe NCs into layer-by-layer films
and by changing the secondary structure of an organophosphate
hydrolase that was conjugated to the surface of the NCs.
In addition, electrochemical resonance based approaches have
also been applied for the detection of OPs.8 All these strategies
involve bioconjugation of enzymes onto the surface of NCs.
In our proposed protocol (Scheme 1a), positively charged
acetylthiocholine (ATCh) was employed as a substrate for AChE
that catalyses the hydrolysis of ATCh to produce thiocholine
(TCh), another positively charged species that bears an addi-
tional thiol group. Both ATCh and TCh prefer to adsorb onto
the surface of negatively charged TGA-CdS NCs via electrostatic
interactions and hydrogen bonding. Yet, TCh is able to cap to
a higher extent on NC surfaces by its SH group followingScheme 1 (a) Illustration of signaling strategy for highly toxic OPs
based on an AChE-ATCh/TGA-CdS NCs system and (b) chemical
structures of investigated OPs, in which two are G-type (sarin (GB) and
soman (GD)), two are V-type (VX and RVX), and one is a pesticide
(paraoxon). All operations were carried out under chemical safety prin-
ciples.
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Fig. 1 Absorption (—) and PL (---) spectra of prepared TGA-CdS NCs






























































View Onlinea known chemistry of thiol capping on NCs.9 Effects of ATCh
and TCh on the amount of vacancies at NC surfaces were
therefore expected to be different, leading to a change in the
surface trap state photoluminescence (PL) of TGA-CdS NCs
that could reflect the amount of OP that inhibits AChE activity.
This forms the basis of our signaling of highly toxic OPs that
affect the enzyme catalytic reaction (Scheme 1a).
Experimental
Apparatus
PL spectra were measured using a Hitachi F-4010 fluorescence
spectrometer (Hitachi Ltd., Japan) controlled by Accessport soft-
ware (a serial port communication software). Absorption spectra
were recorded with a HP-8453 UV-Visible spectrometer (HP Ltd.,
USA). pH measurements were made with an Orion 420 pH meter
(Orion Ltd., USA). Enzyme catalytic reactions were performed in
an Infors AG CH-4103 incubator (Infors AG, Ltd., Swiss).
Reagents
CdCl2$10H2O, Na2S$9H2O, and other inorganic compounds
were purchased from Shanghai Chemicals Group (China). TGA,
AChE and S-acetylthiocholine iodide were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Mercaptoethanol (ME),
mercaptoethylamine (MEA) and dithiobisnitrobenzoate were
obtained from Acros (New Jersey, USA). Sarin (isopropyl
methylphosphonofluoridate), Soman (pinacolyl methyl-
phosphonofluoridate), VX (O-ethyl-S-2-diisopropylaminoethyl
methylphosphonothioate) and Russian (R)VX (O-isobutyl-S-2-
diethylaminoethyl methylphosphonothioate) were obtained from
the Institute of Chemical Defence (China). Paraoxon-ethyl (par-
aoxon) was purchased from Dr. Ehrenstorfer GmbH (Germany).
Procedures
TGA-CdS NC preparation10. 5 mmol CdCl2 and 25 mmol TGA
was dissolved in 40 mL doubly deionized water. After adjusting
the pH to 7.0 by 1.0 M NaOH, 10 mL Na2S aqueous solution
(0.25 M) was added dropwise under vigorous stirring that then
continued for 24 h. CdS NCs were precipitated from the solution
by adding ethanol. The TGA-CdS NCs were then treated in three
repeated cycles of precipitation, washing, and redispersion in
order to remove other components. The purified CdS NC
powder was dried under vacuum and finally dissolved in doubly
deionized water and stored in a refrigerator at 4 C.
Preparation of ATCh. 0.6 mmol S-acetylthiocholine iodide was
dissolved in 5 mL doubly deionized water. 0.7 mmol AgNO3 was
added into the solution to remove I that would severely quench
the PL of the CdS NCs. After removing AgI precipitates by
centrifugation, 0.3 mmol NaCl was added into the solution and
the formed precipitates were removed by further centrifugation.
The resulting solution was immediately used for the following
experiments.
Preparation of TCh11. The enzyme catalytic reaction of AChE
with freshly prepared ATCh was allowed in 50 mM phosphate
buffer of pH 7.6 for 30 min. The final concentration of TCh was2154 | Analyst, 2009, 134, 2153–2157determined by spectrophotometry after reacting with dithio-
bisnitrobenzoate. The resulting solution was immediately used
for the following experiments.
Preparation of stock solutions of OPs. OPs were dissolved in
5 mL hexane and stored in a refrigerator at 4 C. Standard
solutions of OPs were freshly prepared in isopropanol.
Measurement of AChE activity in TGA-CdS NCs/ATCh
system. Varying unit activity of AChE was dissolved in 250 mL
20 mM Tris-HCl pH 7.6 buffer and the solution was incubated at
37 C for 10 min. 10 mL ATCh was then added and incubated at
37 C for 20 min, to which 250 mL TGA-CdS NCs were added.
Final concentrations of ATCh and TGA-CdS NCs were 75 mM
and 500 nM, respectively. PL measurements were carried out
after 10 min incubation at room temperature.
Signaling OPs in TGA-CdS NCs/ATCh system. 10 mL OPs of
varying concentrations were dissolved in 240 mL 20 mM Tris-
HCl buffer (pH 7.6) containing 0.008 unit activity of AChE and
the solution was incubated at 37 C for 10 min. 10 mL ATCh was
then added and incubated at 37 C for 20 min, to which 250 mL
TGA-CdS NCs were added. Final concentrations of ATCh,
TGA-CdS NCs, and AChE were 75 mM, 500 nM, and 0.016 units
mL1, respectively. PL measurements were carried out after
10 min incubation at room temperature.Results and discussion
The prepared TGA-CdS NCs show a well resolved exciton
absorption peaked at 370 nm (Fig. 1), indicating good dispersity
of the NCs. Both the particle size (2.5 nm) and concentration of
NC solutions were calculated according to Peng’s empirical
equations, based on its absorption maximum.12 Broad PL of
TGA-CdS NCs shows a maximum of 541 nm (Fig. 1) featuring
a large Stokes shift, probing the surface-trap emissive state
nature.13
AChE is an esterase that cleaves the ester linkage in ATCh,
producing TCh that bears an additional SH group compared to
ATCh. The effect of AChE on the emission of TGA-CdS
NCs/ATCh system was examined. It was observed that quench-






























































View OnlineAChE concentration (Fig. 2). The PL of TGA-CdS NCs was
found to not be affected by AChE itself (Fig. 3), which means
there is no appreciable interaction between TGA-CdS NCs and
AChE. The AChE concentration-dependent spectral change in
the TGA-CdS NCs/ATCh system was therefore attributed to the
enzymolysis of ATCh. This produces TCh which bears an SH
group that promotes an enhanced interaction of TCh, compared
to ATCh, with the TGA-CdS NCs surface because of a strong
complexation of the SR group in TCh with the TGA-CdS NCs’
surface unbound and/or unsaturated Cd2+ ions.
Indeed, ATCh and ATCh/AChE do exert substantially
different influence on the PL of TGA-CdS NCs (Fig. 3). It was
noted from Fig. 3 that the PL of the TGA-CdS NCs was
enhanced by 1.7-fold and the emission was red-shifted by 10 nm
from 541 nm to 551 nm in the presence of ATCh. In the case of
ATCh/AChE where the species interacting with the TGA-CdS
NCs are ATCh and TCh, the PL was enhanced by 1.1-fold while
the emission was red-shifted by 20 nm. These distinct differences
in the change of PL of NCs are the first support of the differentFig. 2 PL spectra of TGA-CdS NCs in 20 mM pH 7.6 Tris-HCl buffered
ATCh-AChE reaction solution, with different [AChE]. [NCs] ¼ 500 nM,
[ATCh] ¼ 75 mM, lex ¼ 370 nm.
Fig. 3 PL spectra of TGA-CdS NCs in 20 mM Tris-HCl pH 7.6 buffer in
the absence and presence of 0.016 Units mL1 AChE, 1 mM paraoxon
(OP), 75 mM ATCh, and 75 mM ATCh plus 0.016 units mL1 of AChE.
[NCs] ¼ 500 nM, lex ¼ 370 nm.
This journal is ª The Royal Society of Chemistry 2009interactions of ATCh and TCh with TGA-CdS NCs as proposed
in Scheme 1a. In addition, we found that the PL of TGA-CdS
NCs remained unchanged in the presence of only OPs, indicating
that an observable interaction between these inhibitors of AChE
and the TGA-CdS NCs was absent (Fig. 3 and Fig. S1 in ESI†).
It was therefore made clear that it was the difference in the
species that interacted with the TGA-CdS NCs that led to
changes in the PL of TGA-CdS NCs, substantializing the
signaling platform that is sensitive to these highly toxic OPs.
As the activity of AChE could be inhibited by OPs,4 quenching
of the PL of TGA-CdS NCs should be suppressed and blue-shift
in the emission would be observed in the presence of these
inhibitors. Indeed, an increase in the concentration of OPs
(GB, GD, VX, RVX, and paraoxon) at nM level in the AChE/
ATCh enzyme catalytic reaction system was sensitively imparted
by an enhancement in the PL and a blue-shift of the emission of
TGA-CdS NCs (Fig. 4–6, and Fig. S2–S5 in ESI†). These agree
well with the observed relationship of the PL intensity of the
TGA-CdS NCs with AChE activity (Fig. 2). Data in Figs. 5 and 6
clearly indicate that this signaling system exhibits a high sensi-
tivity for these toxic OPs, with excellent limits of detection
(LODs) and wide dynamic ranges. LODs of four nerve agents
GB, GD, VX, and RVX were calculated to be at 0.1 nM level
while the LOD of paraoxon was calculated at 40 nM level;
dynamic ranges for the four nerve agents were found to span two
orders of magnitude, while for paraoxon it spanned across three
orders of magnitude (40 nM–10 mM, Fig. 6).
We had evidence to show that the modulation of the PL of
TGA-CdS NCs results from changes in the amounts of surface
vacancies. In the enzyme catalytic reaction system two species,
ATCh and TCh, that can interact with the surface of TGA-CdS
NCs were found to lead to PL spectral changes to different
extents (Figs. 3 and 7). This is because TCh, bearing an addi-
tional thiol group, has a stronger interaction with the surface
unbounded or weakly bounded Cd2+ ions of TGA-CdS NCs.
This was further verified by variations in the PL of TGA-CdS
NCs in the presence of three differently charged SH-containing
species, mercaptoethylammonium (HSCH2CH2NH3
+, MEA+),
mercaptoethanol (HSCH2CH2OH, ME), and TGA
 (HSCH2CO2
).
Fig. 8 shows that these three compounds lead to PL quenchingFig. 4 PL spectra of TGA-CdS NCs in 20 mM Tris-HCl pH 7.6
buffered reaction solution of AChE, ATCh, and GB. [NCs] ¼ 500 nM,
[AChE] ¼ 0.016 units mL1, [ATCh] ¼ 75 mM, lex ¼ 370 nm.
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Fig. 6 Plot of PL intensity (a) and maximum wavelength (b) versus
concentration of paraoxon in 20 mM Tris-HCl buffer of pH 7.6.
[NCs]¼ 500 nM, [AChE]¼ 0.016 units mL1, [ATCh]¼ 75 mM, lex¼ 370
nm. PL and PL0 represent luminescence intensity of TGA-CdS NCs in
the presence and absence of paraoxon, respectively.
Fig. 5 Plot of PL intensity (a) and maximum wavelength (b) versus
concentration of the four nerve agents. The buffer used was 20 mM Tris-
HCl of pH 7.6, [NCs]¼ 500 nM, [AChE]¼ 0.016 units mL1, [ATCh]¼ 75
mM, lex¼ 370 nm. PL and PL0 represent luminescence intensity of TGA-
CdS NCs in the presence and absence of OPs, respectively.
Fig. 7 Effect of ATCh and TCh on PL/PL0 (a) and maximum PL
wavelength (b) of TGA-CdS NCs. The buffer used was 20 mM Tris-HCl
of pH 7.6, [NCs] ¼ 500 nM, lex ¼ 370 nm. PL and PL0 represent lumi-
nescence intensity of TGA-CdS NCs in the presence and absence of
ATCh or TCh, respectively.
Fig. 8 Plot of PL/PL0 (a) and maximum PL wavelength (b) of TGA-CdS
NCs in the presence of MEA+, ME, and TGA in 20 mM Tris-HCl buffer
of pH 7.6, [NCs] ¼ 500 nM, lex ¼ 370 nm. PL and PL0 represent lumi-































































View Onlineand blue shift in the order of MEA+ > ME > TGA, similar to
that observed with ATCh and TCh (Fig. 7). It should be added
that hydrogen bonding interactions between the introduced SH-
containing compounds and TGA-CdS NCs surface CO2H may
also contribute to the quenching of PL.
The high sensitivity of the signaling was attributed to both the
inhibition of OPs on the catalytic activity of AChE and the
difference in the interaction with TGA-CdS NCs of ATCh and
TCh. The latter difference is efficiently enhanced by the multi-
valent character of the TGA-CdS NCs surface.14 It is understood
that, compared with the cases involving conjugation of bio-
macromolecules, much more small-molecules such as ATCh and
TCh can interact with the surface of TGA-CdS NCs, which
would contribute to the observed higher sensitivity. It should be
pointed out that Au nanoparticles (NPs)-based ATCh/AChE
catalytic systems have recently been developed for the detection
of OPs by means of the interaction of Au NPs with the SH group2156 | Analyst, 2009, 134, 2153–2157in the resulting TCh.15–17 Compared with these strategies, our
work represents a new entry for highly sensitive signaling OPs
based on photoluminescent II–VI group semiconductor NCs
that is, in principle, easily extended to other enzymatic catalytic
reactions for sensitive signaling.Conclusions
In summary, we have developed a simple yet highly sensitive
strategy for detection of toxic OPs by photoluminescent TGA-
CdS NCs in an AChE/ATCh enzyme catalytic reaction medium.
LODs down to 0.1 nM were achieved. The observed significant
signal amplification is the result of a combination of the catalytic
effect of AChE18 and the multivalent effect of the surface of TGA-
CdS NCs that provide more binding sites for the small functional
ligands ATCh and TCh. Differing from most of the reported






























































View Onlinestrategy reported here uses small-molecule substrate and product
with no need of conjugation of bulky biomacromolecules on the
surface of NCs. This provides a new entry for highly sensitive OPs
detection, and more significantly a photoluminescent II–VI group
semiconductor NC-based biosensing protocol that can, in prin-
ciple, be expected for other analytes as well.
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